Viral Vector Manufacturing Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021 - 2026

Report Code: HCR 89466 Report Format: PDF + Excel
1. Viral Vector Manufacturing Market - Overview
        1.1 Definitions and Scope
2. Viral Vector Manufacturing Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Viral Vector Manufacturing Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Viral Vector Manufacturing Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Viral Vector Manufacturing Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Viral Vector Manufacturing Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Viral Vector Manufacturing Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Viral Vector Manufacturing Market - By Type (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Segment Analysis
            8.3.1 Retroviral Vector
                8.3.1.1 Lentiviral Vector
                8.3.1.2 Gamma-Retroviral Vector
            8.3.2 Adenoviral Vector
            8.3.3 Adeno-Associated Viral Vector
            8.3.4 Other Viral Vector
9. Viral Vector Manufacturing Market - By Disease (Market Size -$Million / $Billion)
        9.1 Cancer
        9.2 Genetic Disorder
        9.3 Infectious Disease
        9.4 Other Disease
10. Viral Vector Manufacturing Market - By End User (Market Size -$Million / $Billion)
        10.1 Pharmaceutical And Biopharmaceutical Companies
        10.2 Research Institutes
11. Viral Vector Manufacturing - By Application (Market Size -$Million / $Billion)
        11.1 Segment type Size and Market Share Analysis
        11.2 Application Revenue and Trends by type of Application
        11.3 Application Segment Analysis by Type
            11.3.1 Gene Therapy
            11.3.2 Vaccinology
12. Viral Vector Manufacturing- By Geography (Market Size -$Million / $Billion)
        12.1 Viral Vector Manufacturing Market - North America Segment Research
        12.2 North America Market Research (Million / $Billion)
            12.2.1 Segment type Size and Market Size Analysis
            12.2.2 Revenue and Trends
            12.2.3 Application Revenue and Trends by type of Application
            12.2.4 Company Revenue and Product Analysis
            12.2.5 North America Product type and Application Market Size
                 12.2.5.1 U.S
                 12.2.5.2 Canada
                 12.2.5.3 Mexico
                 12.2.5.4 Rest of North America
        12.3 Viral Vector Manufacturing- South America Segment Research
        12.4 South America Market Research (Market Size -$Million / $Billion)
            12.4.1 Segment type Size and Market Size Analysis
            12.4.2 Revenue and Trends
            12.4.3 Application Revenue and Trends by type of Application
            12.4.4 Company Revenue and Product Analysis
            12.4.5 South America Product type and Application Market Size
                 12.4.5.1 Brazil
                 12.4.5.2 Venezuela
                 12.4.5.3 Argentina
                 12.4.5.4 Ecuador
                 12.4.5.5 Peru
                 12.4.5.6 Colombia
                 12.4.5.7 Costa Rica
                 12.4.5.8 Rest of South America
        12.5 Viral Vector Manufacturing- Europe Segment Research
        12.6 Europe Market Research (Market Size -$Million / $Billion)
            12.6.1 Segment type Size and Market Size Analysis
            12.6.2 Revenue and Trends
            12.6.3 Application Revenue and Trends by type of Application
            12.6.4 Company Revenue and Product Analysis
            12.6.5 Europe Segment Product type and Application Market Size
                 12.6.5.1 U.K
                 12.6.5.2 Germany
                 12.6.5.3 Italy
                 12.6.5.4 France
                 12.6.5.5 Netherlands
                 12.6.5.6 Belgium
                 12.6.5.7 Denmark
                 12.6.5.8 Spain
                 12.6.5.9 Rest of Europe
        12.7 Viral Vector Manufacturing - APAC Segment Research
        12.8 APAC Market Research (Market Size -$Million / $Billion)
            12.8.1 Segment type Size and Market Size Analysis
            12.8.2 Revenue and Trends
            12.8.3 Application Revenue and Trends by type of Application
            12.8.4 Company Revenue and Product Analysis
            12.8.5 APAC Segment - Product type and Application Market Size
                 12.8.5.1 China
                 12.8.5.2 Australia
                 12.8.5.3 Japan
                 12.8.5.4 South Korea
                 12.8.5.5 India
                 12.8.5.6 Taiwan
                 12.8.5.7 Malaysia
                 12.8.5.8 Hong kong
                 12.8.5.9 Rest of APAC
        12.9 Viral Vector Manufacturing - Middle East Segment and Africa Segment Research
        12.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            12.10.1 Segment type Size and Market Size Analysis
            12.10.2 Revenue and Trend Analysis
            12.10.3 Application Revenue and Trends by type of Application
            12.10.4 Company Revenue and Product Analysis
            12.10.5 Middle East Segment Product type and Application Market Size
                 12.10.5.1 Israel
                 12.10.5.2 Saudi Arabia
                 12.10.5.3 UAE
            12.10.6 Africa Segment Analysis
                 12.10.6.1 South Africa
                 12.10.6.2 Rest of Middle East & Africa
13. Viral Vector Manufacturing Market - Entropy
        13.1 New product launches
        13.2 M&A s, collaborations, JVs and partnerships
14. Viral Vector Manufacturing Market - Industry / Segment Competition landscape Premium
        14.1 Market Share Analysis
            14.1.1 Market Share by Country- Top companies
            14.1.2 Market Share by Region- Top 10 companies
            14.1.3 Market Share by type of Application - Top 10 companies
            14.1.4 Market Share by type of Product / Product category- Top 10 companies
            14.1.5 Market Share at global level - Top 10 companies
            14.1.6 Best Practises for companies
15. Viral Vector Manufacturing Market - Key Company List by Country Premium
16. Viral Vector Manufacturing Market Company Analysis
        16.1 Market Share, Company Revenue, Products, M&A, Developments
        16.2 Brammer Bio
        16.3 Cell And Gene Therapy Catapult
        16.4 Cobra Biologics
        16.5 Finvector Vision Therapy
        16.6 Fujifilm Holding Corporation
        16.7 Kaneka Eurogentec
        16.8 Lonza
        16.9 Massbiologics
        16.10 Merck Kgaa
        16.11 Novasep
        16.12 Oxford Biomedica
        16.13 Regenxbio
        16.14 Spark Therapeutic
        16.15 Uniqure
        16.16 Company 15
        16.17 Company 16 & More
*Financials would be provided on a best efforts basis for private companies
17. Viral Vector Manufacturing Market - Appendix
        17.1 Abbreviations
        17.2 Sources
18. Viral Vector Manufacturing Market - Methodology
        18.1 Research Methodology
            18.1.1 Company Expert Interviews
            18.1.2 Industry Databases
            18.1.3 Associations
            18.1.4 Company News
            18.1.5 Company Annual Reports
            18.1.6 Application Trends
            18.1.7 New Products and Product database
            18.1.8 Company Transcripts
            18.1.9 R&D Trends
            18.1.10 Key Opinion Leaders Interviews
            18.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Viral Vector Manufacturing Market, By Type Market 2019-2024 ($M)
1.1 Retroviral Vector Market 2019-2024 ($M) - Global Industry Research
1.1.1 Lentiviral Vector Market 2019-2024 ($M)
1.1.2 Gamma-Retroviral Vector Market 2019-2024 ($M)
1.2 Adenoviral Vector Market 2019-2024 ($M) - Global Industry Research
1.3 Adeno-Associated Viral Vector Market 2019-2024 ($M) - Global Industry Research
2.Global Viral Vector Manufacturing Market, By Disease Market 2019-2024 ($M)
2.1 Cancer Market 2019-2024 ($M) - Global Industry Research
2.2 Genetic Disorder Market 2019-2024 ($M) - Global Industry Research
2.3 Infectious Disease Market 2019-2024 ($M) - Global Industry Research
3.Global Viral Vector Manufacturing Market, By End User Market 2019-2024 ($M)
3.1 Pharmaceutical And Biopharmaceutical Company Market 2019-2024 ($M) - Global Industry Research
3.2 Research Institute Market 2019-2024 ($M) - Global Industry Research
4.Global Viral Vector Manufacturing Market, By Type Market 2019-2024 (Volume/Units)
4.1 Retroviral Vector Market 2019-2024 (Volume/Units) - Global Industry Research
4.1.1 Lentiviral Vector Market 2019-2024 (Volume/Units)
4.1.2 Gamma-Retroviral Vector Market 2019-2024 (Volume/Units)
4.2 Adenoviral Vector Market 2019-2024 (Volume/Units) - Global Industry Research
4.3 Adeno-Associated Viral Vector Market 2019-2024 (Volume/Units) - Global Industry Research
5.Global Viral Vector Manufacturing Market, By Disease Market 2019-2024 (Volume/Units)
5.1 Cancer Market 2019-2024 (Volume/Units) - Global Industry Research
5.2 Genetic Disorder Market 2019-2024 (Volume/Units) - Global Industry Research
5.3 Infectious Disease Market 2019-2024 (Volume/Units) - Global Industry Research
6.Global Viral Vector Manufacturing Market, By End User Market 2019-2024 (Volume/Units)
6.1 Pharmaceutical And Biopharmaceutical Company Market 2019-2024 (Volume/Units) - Global Industry Research
6.2 Research Institute Market 2019-2024 (Volume/Units) - Global Industry Research
7.North America Viral Vector Manufacturing Market, By Type Market 2019-2024 ($M)
7.1 Retroviral Vector Market 2019-2024 ($M) - Regional Industry Research
7.1.1 Lentiviral Vector Market 2019-2024 ($M)
7.1.2 Gamma-Retroviral Vector Market 2019-2024 ($M)
7.2 Adenoviral Vector Market 2019-2024 ($M) - Regional Industry Research
7.3 Adeno-Associated Viral Vector Market 2019-2024 ($M) - Regional Industry Research
8.North America Viral Vector Manufacturing Market, By Disease Market 2019-2024 ($M)
8.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
8.2 Genetic Disorder Market 2019-2024 ($M) - Regional Industry Research
8.3 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
9.North America Viral Vector Manufacturing Market, By End User Market 2019-2024 ($M)
9.1 Pharmaceutical And Biopharmaceutical Company Market 2019-2024 ($M) - Regional Industry Research
9.2 Research Institute Market 2019-2024 ($M) - Regional Industry Research
10.South America Viral Vector Manufacturing Market, By Type Market 2019-2024 ($M)
10.1 Retroviral Vector Market 2019-2024 ($M) - Regional Industry Research
10.1.1 Lentiviral Vector Market 2019-2024 ($M)
10.1.2 Gamma-Retroviral Vector Market 2019-2024 ($M)
10.2 Adenoviral Vector Market 2019-2024 ($M) - Regional Industry Research
10.3 Adeno-Associated Viral Vector Market 2019-2024 ($M) - Regional Industry Research
11.South America Viral Vector Manufacturing Market, By Disease Market 2019-2024 ($M)
11.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
11.2 Genetic Disorder Market 2019-2024 ($M) - Regional Industry Research
11.3 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
12.South America Viral Vector Manufacturing Market, By End User Market 2019-2024 ($M)
12.1 Pharmaceutical And Biopharmaceutical Company Market 2019-2024 ($M) - Regional Industry Research
12.2 Research Institute Market 2019-2024 ($M) - Regional Industry Research
13.Europe Viral Vector Manufacturing Market, By Type Market 2019-2024 ($M)
13.1 Retroviral Vector Market 2019-2024 ($M) - Regional Industry Research
13.1.1 Lentiviral Vector Market 2019-2024 ($M)
13.1.2 Gamma-Retroviral Vector Market 2019-2024 ($M)
13.2 Adenoviral Vector Market 2019-2024 ($M) - Regional Industry Research
13.3 Adeno-Associated Viral Vector Market 2019-2024 ($M) - Regional Industry Research
14.Europe Viral Vector Manufacturing Market, By Disease Market 2019-2024 ($M)
14.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
14.2 Genetic Disorder Market 2019-2024 ($M) - Regional Industry Research
14.3 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
15.Europe Viral Vector Manufacturing Market, By End User Market 2019-2024 ($M)
15.1 Pharmaceutical And Biopharmaceutical Company Market 2019-2024 ($M) - Regional Industry Research
15.2 Research Institute Market 2019-2024 ($M) - Regional Industry Research
16.APAC Viral Vector Manufacturing Market, By Type Market 2019-2024 ($M)
16.1 Retroviral Vector Market 2019-2024 ($M) - Regional Industry Research
16.1.1 Lentiviral Vector Market 2019-2024 ($M)
16.1.2 Gamma-Retroviral Vector Market 2019-2024 ($M)
16.2 Adenoviral Vector Market 2019-2024 ($M) - Regional Industry Research
16.3 Adeno-Associated Viral Vector Market 2019-2024 ($M) - Regional Industry Research
17.APAC Viral Vector Manufacturing Market, By Disease Market 2019-2024 ($M)
17.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
17.2 Genetic Disorder Market 2019-2024 ($M) - Regional Industry Research
17.3 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
18.APAC Viral Vector Manufacturing Market, By End User Market 2019-2024 ($M)
18.1 Pharmaceutical And Biopharmaceutical Company Market 2019-2024 ($M) - Regional Industry Research
18.2 Research Institute Market 2019-2024 ($M) - Regional Industry Research
19.MENA Viral Vector Manufacturing Market, By Type Market 2019-2024 ($M)
19.1 Retroviral Vector Market 2019-2024 ($M) - Regional Industry Research
19.1.1 Lentiviral Vector Market 2019-2024 ($M)
19.1.2 Gamma-Retroviral Vector Market 2019-2024 ($M)
19.2 Adenoviral Vector Market 2019-2024 ($M) - Regional Industry Research
19.3 Adeno-Associated Viral Vector Market 2019-2024 ($M) - Regional Industry Research
20.MENA Viral Vector Manufacturing Market, By Disease Market 2019-2024 ($M)
20.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
20.2 Genetic Disorder Market 2019-2024 ($M) - Regional Industry Research
20.3 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
21.MENA Viral Vector Manufacturing Market, By End User Market 2019-2024 ($M)
21.1 Pharmaceutical And Biopharmaceutical Company Market 2019-2024 ($M) - Regional Industry Research
21.2 Research Institute Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
2.Canada Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
3.Mexico Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
4.Brazil Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
5.Argentina Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
6.Peru Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
7.Colombia Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
8.Chile Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
9.Rest of South America Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
10.UK Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
11.Germany Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
12.France Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
13.Italy Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
14.Spain Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
15.Rest of Europe Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
16.China Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
17.India Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
18.Japan Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
19.South Korea Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
20.South Africa Viral Vector Manufacturing Market Revenue, 2019-2024 ($M)
21.North America Viral Vector Manufacturing By Application
22.South America Viral Vector Manufacturing By Application
23.Europe Viral Vector Manufacturing By Application
24.APAC Viral Vector Manufacturing By Application
25.MENA Viral Vector Manufacturing By Application
26.Lonza, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Merck Kgaa, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Oxford Biomedica, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Cobra Biologics, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Novasep, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Spark Therapeutic, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Kaneka Eurogentec, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Finvector Vision Therapy, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Brammer Bio, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Cell And Gene Therapy Catapult, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Fujifilm Holding Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
37.Uniqure, Sales /Revenue, 2015-2018 ($Mn/$Bn)
38.Regenxbio, Sales /Revenue, 2015-2018 ($Mn/$Bn)
39.Massbiologics, Sales /Revenue, 2015-2018 ($Mn/$Bn)